Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

被引：0
|
作者：
Lowell L. Hart
Renata Ferrarotto
Zoran G. Andric
J. Thaddeus Beck
Janakiraman Subramanian
Davorin Z. Radosavljevic
Bojan Zaric
Wahid T. Hanna
Raid Aljumaily
Taofeek K. Owonikoko
Didier Verhoeven
Jie Xiao
Shannon R. Morris
Joyce M. Antal
Maen A. Hussein
机构：
[1] Florida Cancer Specialists,Medical Oncology
[2] Wake Forest University School of Medicine,Department of Medicine
[3] University of Texas MD Anderson Cancer Center,Department of Thoracic and Head and Neck Medical Oncology
[4] Clinical Hospital Center Bezanijska Kosa,Medical Oncology Department
[5] Department of Medical Oncology and Hematology,Department of Medicine
[6] Highlands Oncology Group,Faculty of Medicine, Institute for Pulmonary Diseases of Vojvodina
[7] Saint Luke’s Hospital,Hematology/Oncology
[8] Institute for Oncology and Radiology of Serbia,Stephenson Cancer Center
[9] University of Novi Sad,Department of Hematology and Medical Oncology
[10] University of Tennessee Graduate School of Medicine,Department of Medical Oncology, AZ Klina Brasschaat
[11] University of Oklahoma,Department of Oncology
[12] Sarah Cannon Research Institute,undefined
[13] Emory University,undefined
[14] University of Antwerp,undefined
[15] G1 Therapeutics,undefined
[16] Inc.,undefined
[17] Florida Cancer Specialists,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Anemia; Chemotherapy; Myelopreservation; Myelosuppression; Neutropenia; Patient-reported outcomes; Small cell lung cancer; Topotecan; Trilaciclib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：350 / 365
页数：15
相关论文
共 50 条
  • [31] Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: A randomized, double-blind, placebo-controlled trial
    Grote, T
    Yeilding, AL
    Castillo, R
    Butler, D
    Fishkin, E
    Henry, DH
    DeLeo, M
    Fink, K
    Sullivan, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9377 - 9386
  • [32] Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
    Smith, Robert E.
    Aapro, Matti S.
    Ludwig, Heinz
    Pinter, Tamas
    Smakal, Martin
    Ciuleanu, Tudor E.
    Chen, Li
    Lillie, Tom
    Glaspy, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1040 - 1050
  • [33] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hanauer, Stephen
    O'Reilly, Terry
    Lester, Robert
    Slatkin, Neal
    Lee, Jimin
    Franklin, Howard
    Bulawski, Angela
    Israel, Robert
    GASTROENTEROLOGY, 2021, 160 (03) : S1 - S2
  • [34] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hanauer, Stephen
    O'Reilly, Terry
    Lester, Robert
    Slatkin, Neal
    Lee, Jimin
    Franklin, Howard
    Bulawski, Angela
    Israel, Robert
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S1 - S1
  • [35] NABUMETONE IN POSTOPERATIVE PAIN - RESULTS OF A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
    PELLERIN, I
    RESTELLI, L
    VAIANI, G
    NATALE, C
    MOVILIA, PG
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 170 - 170
  • [36] RANDOMIZED MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED PHASE II STUDY EVALUATING METMAB, AN ANTIBODY TO MET RECEPTOR, IN COMBINATION WITH ERLOTINIB, IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER
    Spigel, D.
    Ervin, T.
    Ramlau, R.
    Daniel, D.
    Goldschmidt, J.
    Krzakowski, M.
    Godbert, B.
    Yu, W.
    Patel, P. H.
    Peterson, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 7 - 7
  • [37] Results from PIONEER: a randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis
    Radia, Deepti H.
    Sabato, Vito
    Castells, Mariana
    Akin, Cem
    Elberink, Hanneke Oude
    Tashi, Tsewang
    George, Tracy I.
    Roche, Maria
    DeAngelo, Daniel J.
    Gotlib, Jason
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 8 - 9
  • [38] Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel
    Praful Pandey
    Akash Kumar
    Deepam Pushpam
    Sachin Khurana
    Prabhat Singh Malik
    Ajay Gogia
    Elavarasi Arunmozhimaran
    Mamta Bhushan Singh
    Dinu Santha Chandran
    Atul Batra
    Trials, 24
  • [39] Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel
    Pandey, Praful
    Kumar, Akash
    Pushpam, Deepam
    Khurana, Sachin
    Malik, Prabhat Singh
    Gogia, Ajay
    Arunmozhimaran, Elavarasi
    Singh, Mamta Bhushan
    Chandran, Dinu Santha
    Batra, Atul
    TRIALS, 2023, 24 (01)
  • [40] A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell Disease
    Howard, Joanna
    Kuo, Kevin H. M.
    Oluyadi, Abdulafeez
    Shao, Hui
    Morris, Susan
    Zaidi, Ahmar U.
    Van Beers, Eduard J.
    Thien, Swee Lay
    BLOOD, 2021, 138
12345